Podcast: Zydus Lifesciences MD On Rare Disease Focus, Outcomes-Based Digital Transformation

Preparing For A VUCA World

Zydus Lifesciences is building a rare disease-focused pipeline as a differentiating strategy, managing director Sharvil Patel tells Scrip in an interview. Innovation and patient centricity at heart, digital initiatives are being implemented to transform the company into a ‘future ready’ healthcare organization

Scrip Podcast Special
An Audio Interview With Zydus Lifesciences Managing Director Sharvil Patel

“If we don’t change, we don’t grow” said American author and journalist Gail Sheehy. In February, Zydus Cadila (Cadila Healthcare Ltd) shed a 27-year-old identity to emerge as Zydus Lifesciences Ltd, with managing director Sharvil Patel steering an organizational change that sets course for its growth over the next 25 years.

In an interview with Scrip, Patel says at the heart of this transformation is a desire to produce meaningful outcomes...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip